Literature DB >> 2452848

Interferon inhibits Aspergillus fumigatus growth in mice: an activity against an extracellular infection.

R K Maheshwari1, R N Tandon, A R Feuillette, G Mahouy, G Badillet, R M Friedman.   

Abstract

Prophylactic treatment of mice with interferon (IFN) or polyinosinic-polycytidylic acid [poly(I:C)], an IFN inducer, provided significant protection against an extracellular infection by Aspergillus fumigatus in both Swiss and Swiss athymic nude mice. Tunicamycin (TM) treatment inhibits the antifungal activity of IFN and poly(I:C) in these mice. Anti-asialo GM1 or TM [both inhibitors of natural killer (NK) cell function] treatment enhance the severity of A. fumigatus infection. These results suggest that NK cells may play a role in A. fumigatus infection and in the antifungal activity of IFN.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452848     DOI: 10.1089/jir.1988.8.35

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  9 in total

Review 1.  Animal models in interferon research: some current trends.

Authors:  H Schellekens
Journal:  Experientia       Date:  1989-06-15

2.  Enhancement of anti-Aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells.

Authors:  Valérie Gafa; Maria E Remoli; Elena Giacomini; Martina Severa; Renée Grillot; Eliana M Coccia
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

Review 3.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

4.  Human NK cells adapt their immune response towards increasing multiplicities of infection of Aspergillus fumigatus.

Authors:  Lothar Marischen; Anne Englert; Anna-Lena Schmitt; Hermann Einsele; Juergen Loeffler
Journal:  BMC Immunol       Date:  2018-12-18       Impact factor: 3.615

5.  IFN-γ Mediated Signaling Improves Fungal Clearance in Experimental Pulmonary Mucormycosis.

Authors:  Amanda Ribeiro Dos Santos; Thais Fernanda Fraga-Silva; Débora de Fátima Almeida-Donanzam; Rodolfo Ferreira Dos Santos; Angela Carolina Finato; Cleverson Teixeira Soares; Vanessa Soares Lara; Nara Lígia Martins Almeida; Maria Izilda Andrade; Olavo Speranza de Arruda; Maria Sueli Parreira de Arruda; James Venturini
Journal:  Mycopathologia       Date:  2021-10-29       Impact factor: 2.574

6.  Inhibitory effect of interferon-beta on mouse spleen-derived mast cells.

Authors:  S Konno; M Adachi; K Asano; K Okamoto; T Takahashi
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

7.  Stress induced experimental colitis.

Authors:  T A Stein; L Keegan; L J Auguste; B Bailey; L Wise
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

8.  Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.

Authors:  Edward Sionov; Katrin D Mayer-Barber; Yun C Chang; Keith D Kauffman; Michael A Eckhaus; Andres M Salazar; Daniel L Barber; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2015-08-07       Impact factor: 6.823

Review 9.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.